Hannah Daniel
Reporter
Having recently joined the team in 2022, Hannah Daniel is a reporter for Medtech Insight. She is interested in following Rx-to-OTC drug switches and investigating developments from clinical trials. She is the host for HBW’s Over the Counter Podcast U.S. and holds a bachelor’s degree in biology from Carnegie Mellon University.
Latest From Hannah Daniel
Game Time: FDA Releases Review Timeline Goals Set By MDUFA V
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
Small Business Research Grants Reauthorized Under The Wire
Congress extended the Small Business Innovation Research and Small Business Technology Transfer programs, right before they were set to expire on 30 September.
CDC Chooses Five Laboratories For Pathogen Genomics Network
The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.
Software Pre-Certification Program Highlights Needs For Legislative Change, FDA Says
In a report published September 26, the FDA released the findings from its software pre-certification program which include the need for a new regulatory authority to supplement current regulations for medical devices.
Novel Negative Pressure Wound Therapy System Cleared By FDA
The FDA granted 510(k) clearance to Applied Tissue Technologies for its non-foam negative pressure wound therapy system.
Fewer Than Half Of Children On Medicaid Receive Life-Saving Sickle-Cell Screenings, CDC Says
A CDC study found that fewer than half of children with sickle cell disease were getting screened for strokes, and fewer than 40% of children were taking recommended medications.